Source:http://linkedlifedata.com/resource/pubmed/id/17374437
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-9-3
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0302-2838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
951-3; discussion 953-4
|
pubmed:meshHeading |
pubmed-meshheading:17374437-Administration, Intravesical,
pubmed-meshheading:17374437-Antineoplastic Agents,
pubmed-meshheading:17374437-BCG Vaccine,
pubmed-meshheading:17374437-Drug Administration Schedule,
pubmed-meshheading:17374437-Humans,
pubmed-meshheading:17374437-Neoplasm Invasiveness,
pubmed-meshheading:17374437-Urinary Bladder Neoplasms
|
pubmed:year |
2007
|
pubmed:articleTitle |
Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
|
pubmed:publicationType |
Editorial,
Comment
|